A convenient and reliable gas chromatographic method was developed for the simultaneous determination of six aromatic acid metabolites of styrene and styrene-oxide in rat urine: i.e. benzoic (BA), phenylacetic (PAA), mandelic (MA), phenylglyoxylic (PGA), hippuric (HA) and phenylaceturic (PAUA) acids. The method involves a one-pot esterification-extraction procedure, performed directly on urine without prior treatment.
Introduction
Styrene is an important industrial chemical used in the synthesis and manufacture of polystyrene and many copolymers, as well as numerous other industrial resins (1) . Styrene is possibly carcinogenic to humans (2) . The mechanisms for the carcinogenicity of styrene are currently incompletely known, but may include both genotoxic and epigenetic elements. Most of the genotoxic effects associated with exposure to styrene are thought to be caused by its major metabolite, styrene-7,8-oxide (SO). This compound is anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in multiple animal species at multiple tissue sites (3) . SO itself is used as a chemical intermediate in the production of styrene glycol and its derivatives, in the production of cosmetics, surface coatings, and agricultural and biological chemicals. It is also used as a reactive diluent for epoxy resins and in cross-linked polyesters and polyurethanes (3) . Despite its many uses, occupational exposure to SO is primarily linked to styrene oxidation in air (4) .
The metabolism of styrene has been extensively studied. Briefly, as shown in figure 1, styrene is mainly metabolized by cytochrome P450 to form SO. SO is transformed by epoxide hydrolase into styrene glycol. This compound is then metabolized into mandelic acid (MA) and further to phenylglyoxylic acid (PGA). In animals, MA is subsequently converted into benzoic acid (BA) and hippuric acid (HA) after conjugation of BA with glycine (5).
Several minor metabolic pathways have also been described (1) : conjugation of SO with glutathione to ultimately form phenylhydroxylethylmercapturic acids; ring oxidation resulting in the production of vinylphenols and arylmercapturic acids (6) ; cytochrome P450 conversion of styrene to 2-phenylethanol; formation of phenylacetaldehyde from 2-phenylethanol or SO.
This latter pathway leads to the formation of phenylacetic acid (PAA) and phenaceturic acid (PAUA) once conjugated with glycine.
As part of a larger study on comparative genotoxicity of styrene and styrene oxide, we were interested by the measurement of some of the styrene (and SO) metabolites in urine of rats exposed by inhalation to the corresponding vapors. We chose to measure the following metabolites: MA, PGA, BA, HA, PPA and PAUA. All theses acids may also be metabolites of ethylbenzene. BA and HA can be found in the urines of toluene-exposed rats.
Many HPLC methods allowing the simultaneous determination of MA, PGA and HA (and methylhippuric acids (mHAs)) concentrations in urine have been described (7) (8) (9) (10) (11) (12) . In contrast, few studies describe the determination of BA, PPA and PAUA concentrations (13, hal-00743297, version 1 -18 Oct 2012 14). The GC methods developed to determine MA, PGA, HA and mHAs systematically involve a derivation step. This may be silylation, using a mixture of hexamethyldisilazane and trimethylchlorosilane (15) or N-methyl-N-trimethylsilyl-trifluoroacetamide (16); or esterification using methanol and hydrochloric acid (17) or trimethyloxonium tetrafluoroborate as a methylating agent (18) . With these approaches, mass spectrometry detection is often used rather than flame ionization detection (FID), and the derivation steps are generally preceded by solvent extraction of the urine and evaporation of the extract to dryness. These approaches are both time consuming and complex; we therefore sought to develop a simpler, more rapid method to detect the metabolites in rat urine without the need for an extraction step.
We therefore adapted an analytical method previously developed to measure urinary levels of mandelic acid enantiomers (19, 20) for the determination of MA, PGA, BA, HA, PAA & PAUA in rat urine. This method involved esterification of the six acids using 2-propanol, which could be performed without requiring extraction of compounds from the matrix. The analytical method was validated and then applied for quantitative analysis of styrene, styreneoxide, ethylbenzene and toluene metabolites in urine samples from rats exposed to these compounds by inhalation.
Experimental Reagents
Benzoic acid (BA) (>99.5%), hippuric acid (HA) (98%), phenylacetic acid (PAA) (99%), phenylglyoxylic acid (PGA) (>98%), DL-3-phenyllactic acid (PhLA) (>97%), phenylacetyl chloride (98%) and hydrogen chloride -2-propanol solution (1.25 M) were purchased from Sigma-Aldrich (Saint Quentin Fallavier, France). DL-Mandelic acid (MA) (99%), glycine (>99%), anhydrous sodium bicarbonate (>99.8%) and toluene (>99.5%) were obtained from VWR (Fontenay sous Bois, France).
Phenaceturic acid (PAUA) was synthesized using a procedure similar to that used for the production of commercial hippuric acid, i.e. glycine acylation by phenylacetyl chloride (21) .
The seven isopropylester derivatives (iPrEDs) of the six acids to be determined and the selected internal standard (I.S. = DL-3-phenyllactic acid = PhLA) were synthesized separately in the laboratory and characterized before use. g/L (12.01 mM) was also prepared in toluene.
All these stock solutions were stored at 4 °C before use.
Sample preparation
Esterification was performed by adding 10 µL of I.S. solution and 500 µL of HCl 1.25 M in 2-propanol to an aliquot of 100 µL urine. The reaction was carried out for 2 h at 100 °C in hermetically closed 10-mL screw-cap glass vials. After cooling to room temperature, 1000 µL of an aqueous solution of NaHCO 3 (0.7 M) and 500 µL of toluene were added to neutralize remaining reagents and extract reaction products. In these conditions, the quaternary mixture (NaHCO 3 , water, 2-propanol and toluene) gives two single-phase regions and most of the 2-propanol is recovered in the organic toluene phase (22) . The sample was then ready for GC-FID analysis.
GC Conditions
The development and validation of the GC analyses were carried out using a Shimadzu GC-2010 Plus system equipped with a PTV injector, a flame ionization detector and an AOC20i autosampler. GC Solution software (version 2.32) was used for data acquisition and to control the GC system. Samples were separated on a RTX-1701 (with Integra-Guard) capillary column (30 m x 0.25 mm, film thickness 0.25 µm) (Restek, France) with helium as the carrier gas at a constant linear velocity of 40 cm/s. The sample (1 µL) was injected in splitless mode, the split delay and split ratio were set at 0.5 min and 1/50, respectively. The oven temperature was held at 60 °C for 0. The limits of detection (LOD) and quantification (LOQ) were calculated from the calibration curves, and defined as the concentrations for which the corresponding peak-area ratios would be equal to 3 (LOD) and 10 (LOQ) times the standard deviations (n = 5) of the peak-area ratios for the lowest standards.
Recovery studies
The overall procedure recovery reflects the efficiency of both the acid derivatization step and the extraction of the resulting esters.
Global recovery yields were determined at three different concentrations (0.008, 0.08 and 0.8 g/L) by adding known amounts of BA, PAA, MA, PGA, HA and PAUA to urine from a non-exposed rat. Spiked urines were then treated according to the sample preparation procedure described above.
The extraction efficiency for the iPrEDs, was also determined at three different concentrations (0.01, 0.1 and 1 g/L) prepared by serial dilution in toluene. Known amounts of BAiPr, PAAiPr, MAiPr, PGAiPr, HAiPr and PAUAiPr were added to a urine sample from a non-exposed rat, or to water. For these experiments, an adjusted sample preparation procedure was used, where 10 µL water, 100 µL of the esters solution in toluene, 10 µL PhLAiPr in toluene (2.5 g/L), 500 µL of HCl (1.25 M) -2-propanol solution, 390 µL toluene and 1000 µL of aqueous solution of NaHCO 3 (0.7 M) were added to 100 µL blank urine (or water). For this experiment, the oven program temperature of the gas chromatograph was slightly different The recovery yields (procedure recovery and ester extraction efficiency) were calculated for five replicates by concentration level by comparing the amounts of analytes extracted from urine samples with those measured for the corresponding compounds dissolved in toluene.
Assay precision
Quality control (QC) samples were prepared as described above using 0.08, 0.32 and 0.56 g/L solutions. Intra-day precision was assessed by assaying five times each QC sample on the same day. Inter-day precision was determined over three different days. The relative standard deviation (%RSD) was used as an indicator of precision.
Assay of aromatic acids in rat urine after exposure by inhalation
The compounds of interest were measured using the validated method in various urine rat samples collected during independent inhalation experiments carried out in our laboratory for the toxicological assessment of various aromatic compounds (ethylbenzene, styrene, styrene oxide and toluene).
All experiments involving animals were conducted in accordance with the rules provided by the European Union (Directive 2010/63/EU) (24) and were performed in a French Ministry of Agriculture-accredited animal facility.
Before exposure, male Fisher 344 or Sprague-Dawley rats from Charles Rivers Laboratories (L'Arbresle, France) were acclimatized to the experimental laboratory for at least five days with a 12:12 h night/day cycle, and had free access to food and water. Temperature was maintained at 22 ± 2 °C, with a relative humidity of 55 ± 10 %.
Groups of six to eight rats were exposed to ethylbenzene, styrene, styrene oxide or toluene vapors at different concentrations (see Table 1 ) for 6 hours per day over a period ranging from 1 day to 28 days. Unexposed rats were only exposed to clean air. Details of how pollutants were generated and concentrations controlled were reported elsewhere (25) .
Following exposure (9:00 am-3:00 pm), animals were placed in individual metabolic-type stainless steel cages with free access to food and water from 3:00 pm to 9:00 am the following day (days of urine collection are specified in Table 1 ). During this 18h-period, their urine was hal-00743297, version 1 -18 Oct 2012 collected and refrigerated by a cooling system attached to the collection tubes. Urinary samples were frozen immediately after collection and stored at −20 °C . They were thawed just before analysis.
Urinary creatinine concentrations were determined by the Jaffé method using a creatinine test kit (Randox Laboratories, France).
All samples were analyzed in duplicate and a QC sample was added to each series of three samples.
Results and Discussion

Method Validation
Selectivity was evaluated by comparing the chromatograms acquired for extracted blank urine samples (controls from table 1) with those for urine spiked with the iPrED mix solution.
Typical chromatograms for the 0.1 g/L iPrED mix solution in toluene show seven peaks corresponding to the six test compounds and the internal standard (Figure 2a ). Similar chromatogram profiles were obtained for samples extracted from non-exposed rat urine spiked with 0.1 and 0.001 g/L iPrED mix solution (Figures 2b and 2c) . Under the indicated conditions, no interfering peak related to the presence of endogenous matrix components, or to residual reagents hampered detection of the seven iPrED. The two small additional peaks right after the internal standard peak are related to impurities present in the toluene used for the preparation of the mix solution of esters and extraction.
Since BA, PAA, HA and PAUA can be produced endogenously at relatively high concentrations (> 0.2 and 1.0 g/L for PAUA and HA respectively), the calibration curves cannot be prepared in a truly analyte-free urine matrix. The standard addition method was also discarded because it would have required significant extension of the linearity range (nearly doubled for HA). The calibration curves were therefore established by plotting the ratio of peak area for each analyte relative to the peak area for the internal standard vs. the nominal concentrations (g/L) of the calibration standards in water. The method was shown to be linear for BA, PAA, MA and PGA over the full range of concentrations investigated (0.008 -0.8 g/L), the lower limit of linearity was raised to 0.04 g/L for HA and PAUA. It should be noted that our method is among the few with such a wide linearity range. The LODs and LOQs for each compound were determined based on these calibration curves ( Table 2 ). These limits are quite comparable to other works, only two publications using GC-MS techniques show lower limits (17, 18) but in these articles, BA, PAA and PAUA are not considered. HA, PAUA, and, to a lesser extent, BA have higher LODs and LOQs than the three other aromatic acids. For HA and PAUA, this is due to their iPrEDs having a lower extraction yield in toluene (< 60 %, see Table 3 ). For BA, the extraction yield of BAiPr is quite high (> 90% in water), but the esterification yield is low, only allowing about 50% total recovery. This low esterification yield for BA was also observed during BAiPr synthesis.
Extraction efficiency for the all iPrEDs was determined for samples dissolved in water and urine at three concentrations (only two for HAiPr and PAUAiPr). The efficiency of extraction from water or urine was not affected by concentration for any compound. Similarly, overall procedure recoveries are not concentration dependent. Mean (± SD) values are presented in Table 3 . On average, yields for BAiPr, PAAiPr, MAiPr and PGAiPr were slightly (around 9%) lower for samples dissolved in urine than those dissolved in water. No significant differences were observed for HAiPr, PAUAiPr and PhLAiPr. Finally, the mean (± SD) recovery of the internal standard I.S. from urine, calculated from the sample analysis data, was 84.0 ± 12.3. This is not significantly different from the recovery yield for samples dissolved in water; we can thus assume that a water-based standard solution can be used for calibration and quality controls without introducing bias into the analyses.
Intra-day precision was determined by calculating the %RSD for five replicate analyses of QC samples. Intra-day precision was satisfactory, with %RSD less than 5% for BA, PAA, MA and PGA and 9% for HA and PAUA (Table 4) . Concerning the inter-day precision, it is close to an average of 7.9% (± 2.9) for BA, PAA, MA and PGA or 15.5% (± 7.4) for HA and PAUA. This last value is relatively high, but remains acceptable if we consider the urinary concentrations for these two metabolites and the coefficient of variation between exposed subjects, which is around 35%.
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Metabolite assay in urine from rats exposed by inhalation
The method was used to assess exposure to a range of compounds based on levels of metabolites present in urine. The content levels of the six aromatic acids were measured in the urine of rats exposed to styrene oxide, styrene, ethylbenzene or toluene vapors, and compared to levels in non-exposed animals. Typical chromatograms obtained for urine samples from exposed rats (Figure 3 a-c) can be compared with a 0.32g/L QC sample (Figure 3d) . Results are summarized in Table 5 . For all exposure conditions, BA concentrations were low (< 50 mg/g creatinine). However, a trend for increasing concentrations related to increasing atmospheric concentrations of aromatic compounds was observed. Although well resolved chromatographically, the urinary concentrations of PAA could not distinguish exposed rats from control animals for any compound or concentration tested. The background level detected is probably due to the animals' diet. Although less pronounced, a similar problem has been described for HA and PAUA. With these metabolites, exposure to aromatic solvents is identifiable only above a certain threshold. Thus, in the present study, the HA concentration was significantly different from that of control group for animals exposed to SO75, Styr75, Styr250, EtBZn250 and Tol50; while, for PAUA, only the Styr250 and EtBzn250 groups had measurably higher concentrations than control animals. MA and PGA are sensitive markers of exposure to styrene, styrene oxide and ethylbenzene. As expected, they were not detected in either the control or toluene groups. Excretions of these two compounds increased with the level of exposure for a given chemical. Interestingly, the relative levels of these two metabolites were different depending on whether animals were exposed to styrene oxide, styrene or ethylbenzene. After exposure to styrene oxide or styrene, PGA was the major product; whereas MA was the predominant metabolite after ethylbenzene inhalation.
Conclusion
This paper describes the development of a convenient and reliable method for the simultaneous determination of six aromatic carboxylic acids in urine. The method, which involves a one-pot esterification-extraction procedure combined with GC/FID analysis, is robust, selective and sufficiently sensitive to allow detection of these acids in rat urine after exposure by inhalation to aromatic compounds at levels close to the occupational threshold limit values. Provided that this method can be transposed to human urine, it could therefore have applications in biological monitoring, where it could be used on urine samples from workers to measure aromatic acid metabolites. 
